These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 10850402)

  • 1. Goal-oriented, model-based drug regimens: setting individualized goals for each patient.
    Jelliffe R
    Ther Drug Monit; 2000 Jun; 22(3):325-9. PubMed ID: 10850402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model-based, goal-oriented, individualised drug therapy. Linkage of population modelling, new 'multiple model' dosage design, bayesian feedback and individualised target goals.
    Jelliffe RW; Schumitzky A; Bayard D; Milman M; Van Guilder M; Wang X; Jiang F; Barbaut X; Maire P
    Clin Pharmacokinet; 1998 Jan; 34(1):57-77. PubMed ID: 9474473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adaptive control of drug dosage regimens: basic foundations, relevant issues, and clinical examples.
    Jelliffe RW; Maire P; Sattler F; Gomis P; Tahani B
    Int J Biomed Comput; 1994 Jun; 36(1-2):1-23. PubMed ID: 7927847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control.
    Jelliffe RW; Schumitzky A; Van Guilder M; Liu M; Hu L; Maire P; Gomis P; Barbaut X; Tahani B
    Ther Drug Monit; 1993 Oct; 15(5):380-93. PubMed ID: 8249044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?
    Tod MM; Padoin C; Petitjean O
    Clin Pharmacokinet; 2001; 40(11):803-14. PubMed ID: 11735603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The serum digoxin concentration: ten questions to ask.
    Cauffield JS; Gums JG; Grauer K
    Am Fam Physician; 1997 Aug; 56(2):495-503, 509-10. PubMed ID: 9262530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the appropriateness of serum digoxin concentration measurement in a medical group setting.
    Orrico KB; Wu M; Wilson AR
    J Manag Care Pharm; 2011 Nov; 17(9):695-700. PubMed ID: 22050394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of drug dosing methods.
    Burton ME; Vasko MR; Brater DC
    Clin Pharmacokinet; 1985; 10(1):1-37. PubMed ID: 3882303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Do we use digitalis properly in the management of elderly patients suffering from the signs of chronic heart failure?].
    Erdei F; Vendrey R; Dani G; Kovács E; Márk L; Katona A
    Orv Hetil; 2006 Oct; 147(41):1993-6. PubMed ID: 17120690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A two-compartment population pharmacokinetic-pharmacodynamic model of digoxin in adults, with implications for dosage.
    Jelliffe RW; Milman M; Schumitzky A; Bayard D; Van Guilder M
    Ther Drug Monit; 2014 Jun; 36(3):387-93. PubMed ID: 24492383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum drug concentrations in clinical perspective.
    Koch-Weser J
    Ther Drug Monit; 1981; 3(1):3-16. PubMed ID: 7015580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The dosage of cardiotonic agents in infants as a function of their serum levels and pharmacokinetics].
    Nanulescu M; Leucuţa S; Bucerzan C; Samir A; Szabó P
    Rev Pediatr Obstet Ginecol Pediatr; 1990; 39(1):89-94. PubMed ID: 2128721
    [No Abstract]   [Full Text] [Related]  

  • 13. Dynamical dosage regimen calculations in linear pharmacokinetics.
    Iliadis A; Bruno R; Cano JP
    Comput Biomed Res; 1988 Jun; 21(3):203-20. PubMed ID: 3383552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic investigation of digoxin in Japanese neonates.
    Yukawa E; Akiyama K; Suematsu F; Yukawa M; Minemoto M
    J Clin Pharm Ther; 2007 Aug; 32(4):381-6. PubMed ID: 17635340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computerized drug therapy: application of the hand-held microcomputer to dosage regimen design.
    Brouwer KR; Cook J; Steinke M; Gwilt PR
    Int J Biomed Comput; 1985 Jul; 17(1):49-55. PubMed ID: 3840458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-specific antibody fragments in the treatment of digoxin toxicity.
    Chan BS; Buckley NA
    Clin Toxicol (Phila); 2014; 52(8):824-36. PubMed ID: 25089630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of serum drug concentrations in surgical patients.
    Connors JE; DiPiro JT; Sisley JF
    Am J Surg; 1988 Jul; 156(1):68-76. PubMed ID: 3293477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THE POSOLOGY AND TROUGH CONCENTRATIONS OF DIGOXIN IN ADULT AND ELDERLY PATIENTS.
    Bajraktarevic A; Mehmedagic A; Vucicevic K; Kulic M; Miljkovic B
    Acta Pol Pharm; 2016 Sep; 73(5):1361-1368. PubMed ID: 29638076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic estimation for therapeutic dosage regimens (PETDR)--a software program designed to determine intravenous drug dosage regimens for veterinary applications.
    Riviere JE; Frazier DL; Tippitt WL
    J Vet Pharmacol Ther; 1988 Dec; 11(4):390-6. PubMed ID: 3210265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between high serum digoxin levels and toxicity.
    Tuncok Y; Hazan E; Oto O; Guven H; Catalyurek H; Kalkan S
    Int J Clin Pharmacol Ther; 1997 Sep; 35(9):366-8. PubMed ID: 9314088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.